However, they did not observe significant increases in TLR2 expression in the subsequent progression to adenocarcinoma, with TLR1 and TLR6 showing decreased expression levels in carcinomas when compared with premalignant epithelium [16]. The gene discussed is TLR2; the disease is adenocarcinoma.